Companies in Our Event Community:

From Proof-of-Concept to the Clinic:
Exploit Lipid-Carrier Properties for Nucleic Acid & Gene Therapy Delivery with Optimized Safety & Efficacy

LNP - Headlines (1)

Uncover the Potential of Novel Lipid Vehicles for Extrahepatic Delivery

From Proof-of-Concept to the Clinic: Exploit Lipid-Carrier Properties for Nucleic Acid & Gene Therapy Delivery with Optimized Safety & Efficacy

2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought leaders in the field all racing to uncover the potential of lipid-delivery properties.

This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.

Providing a complete picture of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals and beyond, join market-leaders to progress your candidates to the clinic by applying translatable insights to safeguard payload safety and efficacy.

Join AstraZeneca, Beam Therapeutics, Genentech, BMS and more to expedite the next-generation of lipid-based nanoparticle delivery systems closer to patients this August!

2023 World-Class Speaker Faculty Includes:

Daniel Anderson

Professor - Chemical Engineering

Massachusetts Institute of Technology

James Ferguson

Chief Medical Officer

Matinas BioPharma

Jeffrey Clogston

Principal Scientist, Physiochemical Characterization Section Head

Nanotechnology Characterization Laboratory, National Cancer Institute, Leidos Biomedical Research

Julie Shi

Associate Director, Non-Viral Delivery, Cell Therapy Development

Bristol Myers Squibb

Manmohan Singh

Chief Technology Officer

Beam Therapeutics

Shashi Murthy

Co-Founder & CTO

Nanite

Suzanne Saffie-Siebert

Chairwoman & Chief Executive Officer

SiSaf LTD

Theodore Ashburn

President & Chief Executive Officer

Oncorus

What to Expect at the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit:

25+
Industry & Academic Expert Presenters
140+
Nucleic-Acid & Gene Delivery Attendees
3
Jam-Packed Days of Exclusive Content
3
Deep-Dive & Collaborative Workshops

Hear From Our 2022 Attendees:

Excellent event that is poised for massive growth.

Principal Scientist, Merck & Co

merck-logo-9
Lilly logo

Great opportunity to learn in a diverse environment and with brilliant minds!

Senior Scientist, Eli Lilly

Congratulations event organizers for successfully conducting the 1st Next Gen Lipid-Based Nanoparticles Delivery Summit, keep going with more meetings with additional speakers from well established research and organizations in the field.

Oligonucleotide Discovery Professional, Janssen

Janssen_Pharmaceutica_Logo

Thank You to Our 2023 Event Partners:

Other Events in the Series: